Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cys-loop receptors are a major superfamily of pentameric ligand-gated ion channels (pLGICs) that play a fundamental role in fast excitatory and inhibitory synaptic transmission throughout the central and peripheral nervous systems (IUPHAR/BPS Guide to Pharmacology). They are defined by a characteristic 13-amino acid loop in the extracellular N-terminal domain, closed by a disulfide bridge between two cysteine residues (PubMed: 25003714). This superfamily includes the nicotinic acetylcholine receptors (nAChR), gamma-aminobutyric acid type A receptors (GABA-A), glycine receptors (GlyR), and the serotonin type 3 receptor (5-HT3R) (UniProt). These receptors function as molecular switches that convert chemical signals—neurotransmitters—into electrical signals by opening an intrinsic ion-conducting pore upon ligand binding (PubMed: 15816835). Because of their central role in neural signaling, they are critical therapeutic targets for a variety of conditions, including anxiety, insomnia, epilepsy, and chemotherapy-induced nausea (StatPearls). Drugs targeting these receptors range from full agonists and antagonists to positive and negative allosteric modulators, which fine-tune channel activity (PubMed: 21496447).
Agonism, antagonism, and allosteric modulation of ion channel opening to regulate cation or anion conductance across the cell membrane (PubMed: 15816835).
11 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cys-loop receptor (CLR).